Viewing Study NCT01567527


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-03-08 @ 5:51 AM
Study NCT ID: NCT01567527
Status: COMPLETED
Last Update Posted: 2018-08-24
First Post: 2012-03-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-08
Start Date Type: None
Primary Completion Date: 2016-04
Primary Completion Date Type: ACTUAL
Completion Date: 2016-04
Completion Date Type: ACTUAL
First Submit Date: 2012-03-26
First Submit QC Date: None
Study First Post Date: 2012-03-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-09-01
Results First Submit QC Date: None
Results First Post Date: 2018-08-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2017-03-13
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2018-07-24
Last Update Post Date: 2018-08-24
Last Update Post Date Type: ACTUAL